Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL Monday at 6: Known carcinogens hiding in your childâs classroom? WRAL Investigates why some local schools are refusing to take action
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Matinas Biopharma Hl
(NY:
MTNB
)
0.1030
-0.0001 (-0.10%)
Streaming Delayed Price
Updated: 9:51 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Matinas Biopharma Hl
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
May 11, 2023
Via
Benzinga
Why Matinas BioPharma Stock Is Sinking Today
May 11, 2023
BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have ended an mRNA-based collaboration.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 11, 2023
Via
Benzinga
Why Muscle Maker Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket
May 11, 2023
Gainers Audacy, Inc. (NYSE: AUD) gained 75.8% to $0.2337 in pre-market trading after gaining around 16% on Wednesday. The company posted upbeat quarterly sales.
Via
Benzinga
Recap: Matinas BioPharma Hldgs Q1 Earnings
May 10, 2023
Via
Benzinga
Earnings Outlook For Matinas BioPharma Hldgs
March 14, 2023
Via
Benzinga
Matinas BioPharma: Q2 Earnings Insights
August 11, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:15 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
May 11, 2023
It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Thursday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 10, 2023
Via
Benzinga
7 Small-Cap Biotech Stocks with Massive Potential
April 27, 2023
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 19, 2023
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 09, 2023
Via
Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
October 24, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.
Via
Benzinga
Matinas BioPharma Hldgs: Q1 Earnings Insights
May 12, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:15 AM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
May 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
A Preview Of Matinas BioPharma Hldgs's Earnings
May 11, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
HC Wainwright Reiterates Buy Rating On BioNTech, While Lowers Price Target
April 12, 2022
HC Wainwright has reiterated its Buy rating on BioNTech SE (NASDAQ: BNTX) while reducing the price tar
Via
Benzinga
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Matinas BioPharma Inks mRNA-Based Vaccine Pact With BioNTech
April 11, 2022
BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have
Via
Benzinga
Here's Why Matinas BioPharma Shares Are Rising
April 11, 2022
Matinas BioPharma Holdings Inc (NASDAQ: MTNB) shares are trading higher by 10.4% at $0.86 after the company and BioNTech announced an exclusive research collaboration to...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 25, 2022
Good morning, trader! Get ready for one more busy day of investing today with the biggest pre-market stock movers for Friday!
Via
InvestorPlace
34 Stocks Moving in Friday's Pre-Market Session
March 25, 2022
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22...
Via
Benzinga
Matinas BioPharma Updates — Q4 2021 Earnings And Conference Call Recap
March 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...
Via
Benzinga
Matinas BioPharma: Q4 Earnings Insights
March 08, 2022
Matinas BioPharma Hldgs (AMEX:MTNB) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:15 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For March 8, 2022
March 08, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.